| UniProt ID | TMM43_HUMAN | |
|---|---|---|
| UniProt AC | Q9BTV4 | |
| Protein Name | Transmembrane protein 43 | |
| Gene Name | TMEM43 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 400 | |
| Subcellular Localization |
Endoplasmic reticulum. Nucleus inner membrane Multi-pass membrane protein. Retained in the inner nuclear membrane through interaction with EMD and A- and B-lamins. The N- and C-termini are oriented towards the nucleoplasm. The majority of the hydrop |
|
| Protein Description | May have an important role in maintaining nuclear envelope structure by organizing protein complexes at the inner nuclear membrane. Required for retaining emerin at the inner nuclear membrane (By similarity).. | |
| Protein Sequence | MAANYSSTSTRREHVKVKTSSQPGFLERLSETSGGMFVGLMAFLLSFYLIFTNEGRALKTATSLAEGLSLVVSPDSIHSVAPENEGRLVHIIGALRTSKLLSDPNYGVHLPAVKLRRHVEMYQWVETEESREYTEDGQVKKETRYSYNTEWRSEIINSKNFDREIGHKNPSAMAVESFMATAPFVQIGRFFLSSGLIDKVDNFKSLSLSKLEDPHVDIIRRGDFFYHSENPKYPEVGDLRVSFSYAGLSGDDPDLGPAHVVTVIARQRGDQLVPFSTKSGDTLLLLHHGDFSAEEVFHRELRSNSMKTWGLRAAGWMAMFMGLNLMTRILYTLVDWFPVFRDLVNIGLKAFAFCVATSLTLLTVAAGWLFYRPLWALLIAGLALVPILVARTRVPAKKLE | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MAANYSSTS ------CCCCCCCCC | 12.38 | 25732826 | |
| 5 | Phosphorylation | ---MAANYSSTSTRR ---CCCCCCCCCCCC | 10.16 | 28796482 | |
| 6 | Phosphorylation | --MAANYSSTSTRRE --CCCCCCCCCCCCC | 27.26 | 23401153 | |
| 7 | Phosphorylation | -MAANYSSTSTRREH -CCCCCCCCCCCCCC | 18.93 | 23401153 | |
| 8 | Phosphorylation | MAANYSSTSTRREHV CCCCCCCCCCCCCCE | 28.33 | 23401153 | |
| 9 | Phosphorylation | AANYSSTSTRREHVK CCCCCCCCCCCCCEE | 23.12 | 28355574 | |
| 10 | Phosphorylation | ANYSSTSTRREHVKV CCCCCCCCCCCCEEE | 33.56 | 23401153 | |
| 18 | Malonylation | RREHVKVKTSSQPGF CCCCEEEECCCCCCH | 36.65 | 32601280 | |
| 19 | Phosphorylation | REHVKVKTSSQPGFL CCCEEEECCCCCCHH | 36.28 | 23312004 | |
| 20 | Phosphorylation | EHVKVKTSSQPGFLE CCEEEECCCCCCHHH | 22.66 | 22496350 | |
| 21 | Phosphorylation | HVKVKTSSQPGFLER CEEEECCCCCCHHHH | 45.70 | 23312004 | |
| 60 | Phosphorylation | NEGRALKTATSLAEG CCCHHHHHHHHHHCC | 35.70 | - | |
| 99 | Ubiquitination | IGALRTSKLLSDPNY HHHHHHHHHCCCCCC | 53.48 | 21890473 | |
| 102 | Phosphorylation | LRTSKLLSDPNYGVH HHHHHHCCCCCCCCC | 62.55 | - | |
| 114 | Ubiquitination | GVHLPAVKLRRHVEM CCCCCHHHHHHHHHH | 38.08 | - | |
| 122 | Phosphorylation | LRRHVEMYQWVETEE HHHHHHHHEEECCHH | 5.92 | 29759185 | |
| 127 | Phosphorylation | EMYQWVETEESREYT HHHEEECCHHHHCCC | 35.12 | 29759185 | |
| 131 | Methylation | WVETEESREYTEDGQ EECCHHHHCCCCCCC | 44.19 | 115918637 | |
| 159 | 2-Hydroxyisobutyrylation | RSEIINSKNFDREIG HHHHHHCCCCCCCCC | 58.08 | - | |
| 159 | Ubiquitination | RSEIINSKNFDREIG HHHHHHCCCCCCCCC | 58.08 | - | |
| 181 | Phosphorylation | AVESFMATAPFVQIG HHHHHHHCCCHHHHH | 24.07 | 30257219 | |
| 193 | Phosphorylation | QIGRFFLSSGLIDKV HHHHHHHHCCCCCCC | 19.73 | 28674151 | |
| 194 | Phosphorylation | IGRFFLSSGLIDKVD HHHHHHHCCCCCCCC | 39.50 | 28674151 | |
| 199 | Acetylation | LSSGLIDKVDNFKSL HHCCCCCCCCCCCCC | 44.48 | 26051181 | |
| 199 | 2-Hydroxyisobutyrylation | LSSGLIDKVDNFKSL HHCCCCCCCCCCCCC | 44.48 | - | |
| 199 | Ubiquitination | LSSGLIDKVDNFKSL HHCCCCCCCCCCCCC | 44.48 | - | |
| 204 | 2-Hydroxyisobutyrylation | IDKVDNFKSLSLSKL CCCCCCCCCCCHHHC | 57.66 | - | |
| 204 | Ubiquitination | IDKVDNFKSLSLSKL CCCCCCCCCCCHHHC | 57.66 | - | |
| 205 | Phosphorylation | DKVDNFKSLSLSKLE CCCCCCCCCCHHHCC | 21.03 | 26437602 | |
| 207 | Phosphorylation | VDNFKSLSLSKLEDP CCCCCCCCHHHCCCC | 37.37 | 24719451 | |
| 209 | Phosphorylation | NFKSLSLSKLEDPHV CCCCCCHHHCCCCCC | 31.64 | 20068231 | |
| 210 | Ubiquitination | FKSLSLSKLEDPHVD CCCCCHHHCCCCCCC | 62.28 | - | |
| 210 | Acetylation | FKSLSLSKLEDPHVD CCCCCHHHCCCCCCC | 62.28 | 26051181 | |
| 232 | Acetylation | FYHSENPKYPEVGDL CCCCCCCCCCCCCCE | 82.25 | 26051181 | |
| 232 | Ubiquitination | FYHSENPKYPEVGDL CCCCCCCCCCCCCCE | 82.25 | 21890473 | |
| 233 | Phosphorylation | YHSENPKYPEVGDLR CCCCCCCCCCCCCEE | 13.09 | - | |
| 244 | Phosphorylation | GDLRVSFSYAGLSGD CCEEEEEEECCCCCC | 13.43 | - | |
| 249 | Phosphorylation | SFSYAGLSGDDPDLG EEEECCCCCCCCCCC | 38.98 | - | |
| 268 | Methylation | VTVIARQRGDQLVPF EEEEEECCCCEEEEE | 45.14 | 115918641 | |
| 278 | Ubiquitination | QLVPFSTKSGDTLLL EEEEEECCCCCEEEE | 51.77 | - | |
| 282 | Phosphorylation | FSTKSGDTLLLLHHG EECCCCCEEEEEECC | 23.88 | - | |
| 292 | Phosphorylation | LLHHGDFSAEEVFHR EEECCCCCHHHHHHH | 39.24 | - | |
| 307 | Ubiquitination | ELRSNSMKTWGLRAA HHHHCCCCHHHHHHH | 40.73 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TMM43_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TMM43_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TMM43_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| FDFT_HUMAN | FDFT1 | physical | 16169070 | |
| VATE1_HUMAN | ATP6V1E1 | physical | 22939629 | |
| CUL4B_HUMAN | CUL4B | physical | 26186194 | |
| CUL4B_HUMAN | CUL4B | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| H00293 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) | |||||
| OMIM Disease | ||||||
| 604400 | Arrhythmogenic right ventricular dysplasia, familial, 5 (ARVD5) | |||||
| 614302 | Emery-Dreifuss muscular dystrophy 7, autosomal dominant (EDMD7) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |